We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.39B
AUM Growth
+$118M
Cap. Flow
-$190M
Cap. Flow %
-4.31%
Top 10 Hldgs %
15.83%
Holding
1,464
New
104
Increased
519
Reduced
644
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 11.79%
3 Financials 11.13%
4 Industrials 8.9%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIO
1276
Western Asset High Income Opportunity Fund
HIO
$339M
$127K ﹤0.01%
32,100
FIGS icon
1277
FIGS
FIGS
$2.36B
$124K ﹤0.01%
18,362
-10,718
-37% -$77.1K
ERIC icon
1278
Ericsson
ERIC
$33B
$122K ﹤0.01%
20,943
-92,939
-82% -$559K
NXJ
1279
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$119K ﹤0.01%
+10,500
New +$117K
JRS icon
1280
Nuveen Real Estate Income Fund
JRS
$242M
$118K ﹤0.01%
15,610
+471
+3% +$3.69K
MWA icon
1281
Mueller Water Products
MWA
$4.11B
$116K ﹤0.01%
10,773
GEO icon
1282
The GEO Group
GEO
$4.21B
$115K ﹤0.01%
+10,465
New +$102K
ERAS icon
1283
Erasca
ERAS
$6.29B
$113K ﹤0.01%
26,287
+13,143
+100% +$89.1K
AEG icon
1284
Aegon
AEG
$13.9B
$111K ﹤0.01%
21,984
+438
+2% +$2.03K
NUV icon
1285
Nuveen Municipal Value Fund
NUV
$1.9B
$108K ﹤0.01%
12,569
-2,805
-18% -$23.9K
MNKD icon
1286
MannKind Corp
MNKD
$1.26B
$104K ﹤0.01%
19,800
IONQ icon
1287
IonQ
IONQ
$17.2B
$104K ﹤0.01%
30,000
+2,215
+8% +$10.7K
ONDS icon
1288
Ondas Inc
ONDS
$5.35B
$102K ﹤0.01%
63,948
-5,109
-7% -$15K
FSR
1289
DELISTED
Fisker Inc.
FSR
$100K ﹤0.01%
13,780
-630
-4% -$4.69K
VISN
1290
Vistance Networks Inc
VISN
$2.68B
$98.1K ﹤0.01%
13,350
ESRT icon
1291
Empire State Realty Trust
ESRT
$824M
$96.8K ﹤0.01%
14,355
MGF
1292
Aberdeen Government Markets Income Fund
MGF
$92.6M
$95.8K ﹤0.01%
28,956
+170
+0.6% +$560
CHW
1293
Calamos Global Dynamic Income Fund
CHW
$555M
$95.7K ﹤0.01%
17,150
+141
+0.8% +$824
URGN icon
1294
UroGen Pharma
URGN
$2.27B
$93.2K ﹤0.01%
+10,511
New +$99.5K
PSEC icon
1295
Prospect Capital
PSEC
$1.15B
$92.4K ﹤0.01%
13,222
TRHC
1296
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$91.3K ﹤0.01%
18,454
-10,862
-37% -$44.8K
ATRA icon
1297
Atara Biotherapeutics
ATRA
$80.1M
$89.7K ﹤0.01%
1,094
-119
-10% -$12.4K
CRNT icon
1298
Ceragon Networks
CRNT
$197M
$84K ﹤0.01%
44,000
-1,000
-2% -$1.88K
FSLY icon
1299
Fastly Inc
FSLY
$4.52B
$82.7K ﹤0.01%
10,100
-600
-6% -$5.25K
AUPH icon
1300
Aurinia Pharmaceuticals
AUPH
$2.06B
$79.5K ﹤0.01%
18,400
-3,200
-15% -$18.6K

Similar funds

Oppenheimer & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Oppenheimer & Co held 1,464 positions worth $4.39B, up 2.8% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer & Co withdrew a net $190M in Q4 2022, closing 116 positions and reducing 644 holdings. Its most notable exit was State Street SPDR Portfolio Mortgage Backed Bond ETF, an estimated $8.22M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in State Street SPDR Portfolio S&P 500 Value ETF worth $5.18M.

  • Oppenheimer & Co's largest Q4 2022 buy was State Street SPDR Portfolio S&P 500 Value ETF: 133,272 shares worth $5.18M.
  • Oppenheimer & Co added most to iShares Treasury Floating Rate Bond ETF in Q4 2022, an estimated $5.9M increase.
  • Oppenheimer & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $22.8M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio Mortgage Backed Bond ETF in Q4 2022, selling an estimated $8.22M.
  • Oppenheimer & Co's ten largest holdings make up 16% of its $4.39B portfolio in Q4 2022.
  • Oppenheimer & Co opened 104 new positions and closed 116 in Q4 2022.
  • Oppenheimer & Co's portfolio value rose 2.8% quarter-over-quarter to $4.39B.

Based on Oppenheimer & Co's 13F filing for Q4 2022, filed 8 Feb 2023.